Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
GUANIDINOBENZOIC ACID ESTER COMPOUND
Document Type and Number:
WIPO Patent Application WO/2014/142219
Kind Code:
A1
Abstract:
[Problem] To provide a compound useful as a drug for preventing and/or treating kidney disease. [Solution] The inventors studied compounds having trypsin-inhibiting activity, confirmed that guanidinobenzoic acid ester compounds have trypsin-inhibiting activity, and completed the invention. These guanidinobenzoic acid ester compounds can be used as drugs for the prevention and/or treatment of kidney disease (for example, chronic kidney disease, acute glomerulonephritis, acute renal failure, and the like) as alternative drugs to a low-protein diet, and/or as drugs for the prevention and/or treatment of diseases in which trypsin participates (for example, chronic pancreatitis, reflux esophagitis, hepatic encephalopathy, influenza, and the like).

Inventors:
FUJIYASU JIRO (JP)
ASANO TORU (JP)
YAMAKI SUSUMU (JP)
KANEKO OSAMU (JP)
KOIKE YUKA (JP)
IMAIZUMI TOMOYOSHI (JP)
URANO YASUHARU (JP)
SATOU TOMOHKI (JP)
SASAMURA SATOSHI (JP)
Application Number:
PCT/JP2014/056601
Publication Date:
September 18, 2014
Filing Date:
March 13, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ASTELLAS PHARMA INC (JP)
International Classes:
C07C279/18; A61K31/24; A61K31/343; A61K31/381; A61K31/472; A61P13/12; C07D217/26; C07D307/80; C07D333/40; C07D333/68; C07D333/70
Domestic Patent References:
WO2011071048A12011-06-16
WO1997037969A11997-10-16
WO1994013631A11994-06-23
WO1991018869A11991-12-12
WO2011071048A12011-06-16
WO1997037969A11997-10-16
WO2006083781A12006-08-10
Foreign References:
JPH09124571A1997-05-13
JPS5753454A1982-03-30
JPS5289640A1977-07-27
JPS5289640A1977-07-27
JPS5753454A1982-03-30
JPH0753500A1995-02-28
JPH0848664A1996-02-20
JPH09124571A1997-05-13
JPH10306025A1998-11-17
JPH06192085A1994-07-12
Other References:
THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 321, no. 26, 1989, pages 1773 - 1777
AMERICAN JOURNAL OF KIDNEY DISEASES, vol. 41, no. 3, 2003, pages S31 - S34
EVIDENCE-BASED CLINICAL PRACTICE GUIDELINE FOR CKD 2013, 2013, pages 25 - 30
NEPHRON, vol. 74, no. 4, 1996, pages 709 - 712
CLINICAL NEPHROLOGY, vol. 32, 1989, pages 119 - 123
ANTIVIRAL RESEARCH, vol. 92, no. 1, 2011, pages 27 - 36
"Protease Groups of Individuals which Determine Susceptibility to Infection of Influenza Virus and Pathogenesis of Influenza-Associated Encephalopathy", THE JAPANESE JOURNAL OF PHARMACOLOGY, vol. 122, 2003, pages 45 - 53
PROG. MED., vol. 5, 1985, pages 2157 - 2161
"Molecular Design", vol. 7, 1990, HIROKAWA PUBLISHING COMPANY, article "Pharmaceutical Research and Development", pages: 163 - 198
P. G. M. WUTS; T. W. REENE: "Greene's Protective Groups in Organic Synthesis", 2006
JOURNAL OF MEDICINAL CHEMISTRY, vol. 46, no. 12, 2003, pages 2446 - 2455
TETRAHEDRON LETTERS, vol. 34, no. 21, 1993, pages 3389 - 3392
M. HUDLICKY: "ACS Monograph: 188", 1996, ACS, article "Reductions in Organic Chemistry"
"Jikken Kagaku Koza", vol. 19, 2005, MARUZEN
"Anti-mouse Trypsin Antibody", SANTA CRUZ BIOTECHNOLOGY, INC.
Attorney, Agent or Firm:
MORITA, Hiroshi et al. (JP)
Morita 拓 (JP)
Download PDF:



 
Previous Patent: FRESHNESS-KEEPING FILM

Next Patent: ANTI-TUMOR AGENT